Strategies for delivering therapeutics across the blood–brain barrier
Georg C. TerstappenCambrian Biopharma, New York, NY, USA. [email protected]Axel H. MeyerDMPK and Bioanalytical Research, AbbVie Deutschland GmbH & Co KG, Ludwigshafen, GermanyRobert D. BellRare Disease Research Unit, Worldwide Research, Development and Medicine, Pfizer, Cambridge, MA, USAWandong ZhangDepartment of Cellular and Molecular Medicine, Faculty of Medicine, Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada
2021en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references